US 12,343,270 B2
Medical stents
Martyn G. Folan, Galway (IE)
Assigned to BOSTON SCIENTIFIC SCIMED, INC., Maple Grove, MN (US)
Filed by BOSTON SCIENTIFIC SCIMED INC., Maple Grove, MN (US)
Filed on Feb. 22, 2021, as Appl. No. 17/181,354.
Application 17/181,354 is a continuation of application No. 16/100,334, filed on Aug. 10, 2018, granted, now 10,945,866.
Claims priority of provisional application 62/545,179, filed on Aug. 14, 2017.
Prior Publication US 2021/0196486 A1, Jul. 1, 2021
Int. Cl. A61F 2/88 (2006.01); A61F 2/86 (2013.01); A61F 2/90 (2013.01)
CPC A61F 2/90 (2013.01) [A61F 2/86 (2013.01); A61F 2/88 (2013.01); A61F 2230/0091 (2013.01); A61F 2250/0014 (2013.01); A61F 2250/0026 (2013.01); A61F 2250/0067 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An implantable stent comprising:
a braided tubular member formed of a plurality of braided wires, the braided tubular member being radially expandable from a radially contracted state to a nominally deployed state, the braided tubular member including a plurality of radially outward wire segments crossing over and positioned radially outward of a plurality of radially inward wire segments at a plurality of crossover points;
wherein the radially inward wire segments contact the radially outward wire segments along a contact length of the radially outward wire segments at the crossover points in the radially contracted state, the contact length being greater than a diameter of the radially inward wire segments; and
a coating extending only partially around a circumference of the radially outward wire segments at the crossover points, such that an uncoated length of the radially outward wire segments is greater than the contact length.